anidulafungin has been researched along with Acute Liver Injury, Drug-Induced in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Liu, P; Mould, DR | 1 |
| Jiang, Y; Jung, DS; Kontoyiannis, DP; Tverdek, FP | 1 |
| Azanza, JR; Montejo, M | 1 |
| Bowman, CJ; Chmielewski, G; Cross, DM; Lewis, E; Ripp, S; Sawaryn, CM | 1 |
| De Rosa, FG; Di Perri, G; Manzione, NA; Messina, M; Ottobrelli, A; Ranghino, A; Raviolo, S; Segoloni, GP | 1 |
2 review(s) available for anidulafungin and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Pharmacokinetics and pharmacodynamics: interactions and adverse effects. Comparison with other echinocandins].
Topics: Aged; Anidulafungin; Antifungal Agents; Caspofungin; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug Monitoring; Echinocandins; Gastrointestinal Diseases; Half-Life; Humans; Immunosuppressive Agents; Lipopeptides; Liver; Liver Failure; Mycoses; Obesity; Renal Insufficiency; Tissue Distribution | 2008 |
5 other study(ies) available for anidulafungin and Acute Liver Injury, Drug-Induced
| Article | Year |
|---|---|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Population pharmacokinetic-pharmacodynamic analysis of voriconazole and anidulafungin in adult patients with invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Area Under Curve; Aspergillosis; Aspergillus; Biological Availability; Chemical and Drug Induced Liver Injury; Double-Blind Method; Drug Administration Schedule; Echinocandins; Female; Half-Life; Hallucinations; Humans; Male; Middle Aged; Models, Statistical; Photophobia; Prospective Studies; Voriconazole | 2014 |
Switching to anidulafungin from caspofungin in cancer patients in the setting of liver dysfunction is associated with improvement of liver function tests.
Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Caspofungin; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Female; Humans; Lipopeptides; Liver Function Tests; Male; Middle Aged; Mycoses; Neoplasms; Retrospective Studies; Young Adult | 2015 |
Juvenile toxicity assessment of anidulafungin in rats: an example of navigating case-by-case study design through scientific and regulatory challenges.
Topics: Abnormalities, Drug-Induced; Anidulafungin; Animals; Antifungal Agents; Behavior, Animal; Brain; Chemical and Drug Induced Liver Injury; Cognition; Dose-Response Relationship, Drug; Echinocandins; Female; Male; Motor Activity; Pregnancy; Rats; Rats, Inbred F344; Research Design | 2011 |
Anidulafungin treatment in a kidney transplant recipient with hepatic damage.
Topics: Anidulafungin; Antifungal Agents; Chemical and Drug Induced Liver Injury; Echinocandins; Female; Fluconazole; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Transplantation | 2011 |